1. Home
  2. INAB vs FEAM Comparison

INAB vs FEAM Comparison

Compare INAB & FEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INAB
  • FEAM
  • Stock Information
  • Founded
  • INAB 2016
  • FEAM 2016
  • Country
  • INAB United States
  • FEAM United States
  • Employees
  • INAB N/A
  • FEAM N/A
  • Industry
  • INAB Biotechnology: Pharmaceutical Preparations
  • FEAM Major Chemicals
  • Sector
  • INAB Health Care
  • FEAM Industrials
  • Exchange
  • INAB Nasdaq
  • FEAM Nasdaq
  • Market Cap
  • INAB 18.8M
  • FEAM 18.6M
  • IPO Year
  • INAB 2021
  • FEAM N/A
  • Fundamental
  • Price
  • INAB $0.27
  • FEAM $4.48
  • Analyst Decision
  • INAB Strong Buy
  • FEAM Strong Buy
  • Analyst Count
  • INAB 3
  • FEAM 2
  • Target Price
  • INAB $5.57
  • FEAM $121.00
  • AVG Volume (30 Days)
  • INAB 14.2M
  • FEAM 17.9K
  • Earning Date
  • INAB 03-13-2025
  • FEAM 02-13-2025
  • Dividend Yield
  • INAB N/A
  • FEAM N/A
  • EPS Growth
  • INAB N/A
  • FEAM N/A
  • EPS
  • INAB N/A
  • FEAM N/A
  • Revenue
  • INAB N/A
  • FEAM N/A
  • Revenue This Year
  • INAB N/A
  • FEAM N/A
  • Revenue Next Year
  • INAB N/A
  • FEAM $200.00
  • P/E Ratio
  • INAB N/A
  • FEAM N/A
  • Revenue Growth
  • INAB N/A
  • FEAM N/A
  • 52 Week Low
  • INAB $0.22
  • FEAM $3.60
  • 52 Week High
  • INAB $1.74
  • FEAM $57.04
  • Technical
  • Relative Strength Index (RSI)
  • INAB 47.53
  • FEAM 28.88
  • Support Level
  • INAB $0.25
  • FEAM $3.60
  • Resistance Level
  • INAB $0.30
  • FEAM $8.33
  • Average True Range (ATR)
  • INAB 0.04
  • FEAM 1.20
  • MACD
  • INAB 0.00
  • FEAM -0.29
  • Stochastic Oscillator
  • INAB 19.95
  • FEAM 12.37

About INAB IN8bio Inc.

IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.

About FEAM 5E Advanced Materials Inc.

5E Advanced Materials Inc is an exploration stage company focused on becoming a vertically integrated supplier of specialty boron and boron derivative materials whose mission is to enable decarbonization, increase food security, and ensure domestic supply of critical materials. It has a project located in southern California underpinned by a mineral resource that includes boron and lithium, with the boron being contained in a conventional boron mineral known as colemanite. The company seeks to extract and process the minerals into boric acid, boron materials, lithium carbonate, and potentially other co-products on a commercial scale.

Share on Social Networks: